GIM
EXAS

Granahan Investment Management’s Exact Sciences EXAS Stock Holding History

Granahan Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-57,212
Closed -$5.81M – 155
2025
Q4 		$5.81M Sell
57,212
-224,706
-80% -$18M 0.25% 95
2025
Q3 		$15.4M Sell
281,918
-40,589
-13% -$2.03M 0.63% 43
2025
Q2 		$17.1M Sell
322,507
-15,368
-5% -$781K 0.7% 40
2025
Q1 		$14.6M Sell
337,875
-106,189
-24% -$5.38M 0.73% 44
2024
Q4 		$25M Buy
444,064
+33,823
+8% +$2.1M 1.04% 32
2024
Q3 		$27.9M Buy
+410,241
New +$23.2M 1.1% 21
2021
Q1 		– Sell
-15,876
Closed -$2.1M – 198
2020
Q4 		$2.1M Sell
15,876
-29,393
-65% -$3.55M 0.05% 174
2020
Q3 		$4.62M Sell
45,269
-126,591
-74% -$10.9M 0.16% 113
2020
Q2 		$14.9M Sell
171,860
-164,695
-49% -$13.2M 0.54% 55
2020
Q1 		$19.5M Buy
336,555
+53,380
+19% +$4.33M 1.05% 24
2019
Q4 		$26.2M Buy
283,175
+78,520
+38% +$6.9M 1.21% 22
2019
Q3 		$18.5M Sell
204,655
-11,968
-6% -$1.36M 1.02% 27
2019
Q2 		$25.6M Sell
216,623
-57,321
-21% -$5.78M 1.26% 21
2019
Q1 		$23.7M Sell
273,944
-115,196
-30% -$9.81M 1.27% 19
2018
Q4 		$24.6M Sell
389,140
-52,502
-12% -$3.6M 1.74% 11
2018
Q3 		$34.9M Buy
441,642
+26,505
+6% +$1.73M 1.89% 7
2018
Q2 		$24.8M Buy
415,137
+115,507
+39% +$6.22M 1.5% 14
2018
Q1 		$12.1M Buy
299,630
+91,560
+44% +$4.47M 0.87% 32
2017
Q4 		$10.9M Sell
208,070
-186,225
-47% -$9.94M 0.86% 35
2017
Q3 		$18.6M Buy
394,295
+10,101
+3% +$407K 1.55% 11
2017
Q2 		$13.6M Sell
384,194
-359,745
-48% -$11.1M 1.25% 17
2017
Q1 		$17.6M Sell
743,939
-2,329,661
-76% -$46.2M 1.76% 7
2016
Q4 		$41.1M Buy
3,073,600
+1,172,050
+62% +$18.9M 1.41% 9
2016
Q3 		$35.3M Buy
1,901,550
+811,710
+74% +$14.3M 1.16% 16
2016
Q2 		$13.4M Buy
+1,089,840
New +$8.21M 0.49% 81
2015
Q4 		– Sell
-641,095
Closed -$11.5M – 243
2015
Q3 		$11.5M Buy
641,095
+272,600
+74% +$6.26M 0.36% 104
2015
Q2 		$11M Sell
368,495
-209,615
-36% -$5.27M 0.31% 117
2015
Q1 		$12.7M Buy
578,110
+138,881
+32% +$3.52M 0.36% 100
2014
Q4 		$12.1M Sell
439,229
-425,817
-49% -$10.4M 0.35% 104
2014
Q3 		$16.8M Sell
865,046
-1,408,304
-62% -$25.8M 0.52% 74
2014
Q2 		$38.7M Buy
2,273,350
+75,217
+3% +$1.04M 1.13% 20
2014
Q1 		$31.1M Buy
2,198,133
+86,290
+4% +$1.17M 0.84% 36
2013
Q4 		$24.8M Buy
+2,111,843
New +$24.2M 0.64% 60

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Granahan Investment Management's EXAS Position: Q1 2026 in Review

Granahan Investment Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 57,212 shares — an estimated $5.81M sold.

Granahan Investment Management first reported a position in EXAS in Q4 2013 and held it in 33 quarters. The position peaked at $41.1M in Q4 2016. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Granahan Investment Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Granahan Investment Management sold 57,212 Exact Sciences shares in Q1 2026, an estimated $5.81M.
  • Granahan Investment Management first reported a position in Exact Sciences in Q4 2013 and held it in 33 quarters.
  • Granahan Investment Management's Exact Sciences position peaked at $41.1M in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Granahan Investment Management's 13F filing for Q1 2026, filed 15 May 2026.